Board of Directors

Christopher Walsh

General Counsel
Denali Therapeutics
Christopher Walsh

Chris Walsh is General Counsel of Denali Therapeutics. As a strategic partner to Denali’s management team and Board, Chris leads the company’s legal function, overseeing the legal strategy across corporate governance, public-company securities and disclosures, collaborations and contracts, intellectual property, commercial readiness, employment, and litigation, in support of Denali’s mission.

Before joining Denali, Chris held positions of increasing responsibility at Genentech, where he guided intellectual property strategy across multiple therapeutic programs. Earlier in his career, he practiced patent law at Sterne, Kessler, Goldstein & Fox. Chris holds a Ph.D. in Organic Chemistry from the Illinois Institute of Technology and received his J.D. from The George Washington University Law School.

Get Involved

Whether you're a startup founder, global company, policymaker, or partner, there's a place for you in our thriving ecosystem.
Explore Benefits Stay Connected Contact Us